H2 2018 PBI-4050 partnership(s) $$$ H2 2018 IPF phase 3 trial
H2 2018 Alstrom phase 3 trial
H1 2019 FDA Ryplazim marketing approval $$$
H1 2019 FDA awards pediatric voucher $$$
H1 2019 regional Ryplazim partnerships $$$
H1 2019 Tympanic Repair data readout
H1 2019 IVIG Canada marketing approval $$$
H2 2019 IVIG FDA marketing approval $$$
H2 2019 PBI-4050 U.K. marketing approval to Alstrom patients $$$